Projects per year
Fingerprint
Dive into the research topics where Gloria M Petersen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds
Fernandez-Zapico, M. E., Fernandez-Zapico, M. E. & Petersen, G. M.
8/17/16 → 7/31/21
Project: Research project
-
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
Petersen, G. M. & Zaret, K. S.
7/15/16 → 6/30/21
Project: Research project
-
-
-
Research output
-
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers
Glioma International Case-Control Study (GICC), International Lung Cancer Consortium (ILCCO), Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium, International Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies (InterLymph), Ovarian Cancer Association Consortium (OCAC), Oral Cancer GWAS, Pancreatic Cancer Case-Control Consortium (PanC4), Pancreatic Cancer Cohort Consortium (PanScan), Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL), Renal Cancer GWAS, Testicular Cancer Consortium (TECAC), Breast Cancer Association Consortium (BCAC), Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON), Colon Cancer Family Registry (CCFR), Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT), Endometrial Cancer Association Consortium (ECAC), Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) & Melanoma Genetics Consortium (GenoMEL), Dec 1 2020, In: Nature communications. 11, 1, 3353.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Associations between genetically predicted blood protein biomarkers and pancreatic cancer risk
Zhu, J., Shu, X., Guo, X., Liu, D., Bao, J., Milne, R. L., Giles, G. G., Wu, C., Du, M., White, E., Risch, H. A., Malats, N., Duell, E. J., Goodman, P. J., Li, D., Bracci, P., Katzke, V., Neale, R. E., Gallinger, S., van Den Eeden, S. K. & 17 others, , Jul 2020, In: Cancer Epidemiology Biomarkers and Prevention. 29, 7, p. 1501-1508 8 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Gallbladder disease, cholecystectomy, and pancreatic cancer risk in the International Pancreatic Cancer Case-Control Consortium (PanC4)
Rosato, V., Negri, E., Bosetti, C., Malats, N., Gomez-Rubio, P., Consortium, P. G. EU., Maisonneuve, P., Miller, A. B., Bueno-De-Mesquita, H. B., Baghurst, P. A., Zatonski, W., Petersen, G. M., Scelo, G., Holcatova, I., Fabianova, E., Serraino, D., Olson, S. H., Vioque, J., Lagiou, P., Duell, E. J. & 2 others, , Sep 1 2020, In: European Journal of Cancer Prevention. 29, 5, p. 408-415 8 p.Research output: Contribution to journal › Article › peer-review
-
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
Glasgow Precision Oncology Laboratory & Australian Pancreatic Cancer Genome Initiative, May 12 2020, In: Cell reports. 31, 6, 107625.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Incorporating multiple sets of eQTL weights into gene-by-environment interaction analysis identifies novel susceptibility loci for pancreatic cancer
Yang, T., Tang, H., Risch, H. A., Olson, S. H., Peterson, G., Bracci, P. M., Gallinger, S., Hung, R. J., Neale, R. E., Scelo, G., Duell, E. J., Kurtz, R. C., Khaw, K. T., Severi, G., Sund, M., Wareham, N., Amos, C. I., Li, D. & Wei, P., Nov 2020, In: Genetic epidemiology. 44, 8, p. 880-892 13 p.Research output: Contribution to journal › Article › peer-review